Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Xlife Sciences AG: Xlife Sciences shares traded on XETRA



DGAP-Media / 01.07.2020 / 07:30

As of today, the shares of Xlife Sciences AG are traded in cooperation with the designated sponsor M.M.Warburg & CO on the electronic trading system XETRA of the Frankfurt Stock Exchange.
XETRA is by far the most important electronic trading venue in Germany with approximately 90% of all equity transactions in Germany occurring there. The ability to trade Xlife Sciences AG shares on XETRA will significantly increase trading volumes. Higher liquidity will result in tighter bid/ask spreads and orders will be able to be executed faster. The overall result will be more consistent and stable pricing.
Thus, Xlife Sciences AG continues focusing on the needs of its investors and further cultivates relationships with institutional investors

About Xlife Sciences AG

Xlife Sciences AG (m:access: XLS) is a Swiss company with focus on investing in promising technologies in the life science industry. Xlife Sciences AG is building the bridge from research and development to healthcare markets. Together with industrial partners or universities, Xlife Sciences AG leads projects through the proof-of-concept phase after an invention disclosure or start-up. Subsequently, the firm focuses on out-licensing or selling the company, often with a combination of a strategic partnership. Xlife Sciences AG offers its investors direct access to the further development of innovative and future-oriented technologies at a very early stage.
For more information, please visit: www.xlifesciences.ch



End of Media Release


Issuer: Xlife Sciences AG
Key word(s): Research/Technology

01.07.2020 Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Xlife Sciences AG
Klausstrasse 19
8008 Zürich
Switzerland
Phone: 0041 44 385 84 60
E-mail: [email protected]
Internet: www.xlifesciences.ch
ISIN: CH0461929603
WKN: A2PK6Z
Listed: Regulated Unofficial Market in Munich
EQS News ID: 1081909

 
End of News DGAP Media

1081909  01.07.2020 

fncls.ssp?fn=show_t_gif&application_id=1081909&application_name=news&site_id=sharewise

Xlife Sciences AG Stock

€42.20
-0.460%
The price for the Xlife Sciences AG stock decreased slightly today. Compared to yesterday there is a change of €0.000 (-0.460%).

Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments